IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial

Quốc gia: Úc

Ngôn ngữ: Tiếng Anh

Nguồn: Department of Health (Therapeutic Goods Administration)

Thành phần hoạt chất:

tremelimumab, Quantity: 25 mg

Sẵn có từ:

AstraZeneca Pty Ltd

Dạng dược phẩm:

Injection, concentrated

Thành phần:

Excipient Ingredients: disodium edetate; histidine hydrochloride monohydrate; polysorbate 80; trehalose dihydrate; water for injections; histidine

Tuyến hành chính:

Intravenous Infusion

Các đơn vị trong gói:

1 vial

Loại thuốc theo toa:

(S4) Prescription Only Medicine

Chỉ dẫn điều trị:

Hepatocellular Carcinoma (HCC),IMJUDO in combination with durvalumab is indicated for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC) who have not received prior treatment with a PD-1/PD-L1 inhibitor.

Tóm tắt sản phẩm:

Visual Identification: Clear to slightly opalescent, colourless to slightly yellow solution, free from or practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 48 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Tình trạng ủy quyền:

Registered

Ngày ủy quyền:

2023-06-23